Adversarial Factor Models for the Generation of Improved Autism Diagnostic Biomarkers

William E. Carson Iv, Dmitry Yu. Isaev, Samantha Major, Guillermo Sapiro, Geraldine Dawson, David E. CarlsonarXiv 2021 · OpenReview

Introduction

Identifying reliable biomarkers for Autism Spectrum Disorder (ASD) is complicated by significant confounding variables, most notably Intellectual Disability (ID). Approximately 40% of individuals with ASD also present with ID. Consequently, machine learning models trained on behavioral or neurophysiological data often inadvertently learn to detect cognitive impairment rather than the core neurodevelopmental features of autism. This lack of specificity hinders the development of clinically useful diagnostic tools. Furthermore, multimodal data—such as electroencephalography (EEG) and eye-tracking behavior—often contain redundant information, as brain activity fundamentally drives behavior.

Methodology: Adversarial PCA (aPCA)

To address these challenges, researchers have developed Adversarial Linear Factor Models, or adversarial PCA (aPCA). Unlike standard PCA, which maximizes explained variance, aPCA incorporates an adversarial objective to "disentangle" latent representations from confounding variables or redundant modalities.

The framework employs a minimax objective involving two components:

  1. The Encoder: Learns a low-dimensional representation of the input data.
  2. The Adversary: Attempts to predict the confounding variable (e.g., IQ) from the encoder's output.

The encoder is optimized to represent the data accurately while simultaneously making it impossible for the adversary to predict the confounder. A significant advantage of this linear formulation is that it possesses an analytical solution via an augmented eigenspace, avoiding the training instabilities common in non-linear adversarial networks like GANs.

Experimental Dataset

The model was evaluated using a cohort of 62 children (31 ASD, 31 typically-developing (TD)). Data modalities included:

  • EEG Features: Power spectral density across four frequency bands (theta, alpha, beta 1, beta 2) recorded during video stimuli.
  • Behavioral Features: Average Look Duration (ALD) during video segments.
  • Concomitant Data: Participant IQ scores served as the primary confounding variable to be removed.

Results and Discussion

Decoupling IQ from Behavioral Features

A primary goal was to ensure biomarkers are not mere proxies for IQ. Raw behavioral features were found to be highly predictive of IQ (AUC = 0.701). By applying aPCA, the researchers successfully reduced the IQ-prediction AUC to 0.500 (random chance), effectively stripping the cognitive confounder from the behavioral representation. While this resulted in a slight decrease in raw diagnostic accuracy, the resulting "pure" biomarker is more specific to the underlying pathology of ASD.

Figure 4: Pareto curve showing the trade-off between diagnostic AUC and IQ group AUC, alongside the reduction in R-squared between aPCA components and IQ as adversarial strength increases.

Multimodal Integration and the "Sweet Spot"

When integrating EEG and behavioral data, aPCA was used to remove redundant behavioral information from the EEG features. This forced the model to capture unique, non-redundant signals from each modality. The study highlights a characteristic trade-off: as adversarial strength (the $\mu$ parameter) increases, redundant information is removed, but excessive strength can eventually degrade the primary signal.

Figure 6: Diagnostic AUC for adversarially generated multimodal features as a function of adversarial strength, showing a peak performance region.

The aPCA approach achieved a multimodal diagnostic AUC of 0.813, significantly outperforming naive concatenation (AUC 0.680) and standard PCA (AUC 0.787). Moreover, aPCA achieved this superior performance using only 19 features, compared to 39 in the raw set, demonstrating a more efficient and robust representation of the disease state.

Conclusion and Future Work

Adversarial PCA provides a mathematically grounded method for generating "clean" biomarkers by explicitly removing confounding and redundant information. While currently limited by a small sample size (n=62), this proof-of-concept demonstrates that aPCA can improve both the specificity and performance of multimodal diagnostic tools for ASD. Future work will explore applying these methods to larger datasets and potentially extending the framework to non-linear deep learning architectures.

Summary updated

Abstract

Discovering reliable measures that inform on autism spectrum disorder (ASD) diagnosis is critical for providing appropriate and timely treatment for this neurodevelopmental disorder. In this work we present applications of adversarial linear factor models in the creation of improved biomarkers for ASD diagnosis. First, we demonstrate that an adversarial linear factor model can be used to remove confounding information from our biomarkers, ensuring that they contain only pertinent information on ASD. Second, we show this same model can be used to learn a disentangled representation of multimodal biomarkers that results in an increase in predictive performance. These results demonstrate that adversarial methods can address both biomarker confounds and improve biomarker predictive performance.
BibTeX
@misc{iv2021adversarial,
  author = {William E. Carson IV and Dmitry Yu. Isaev and Samantha Major and Guillermo Sapiro and Geraldine Dawson and David E. Carlson},
  title = {{Adversarial Factor Models for the Generation of Improved Autism Diagnostic Biomarkers}},
  year = {2021},
  eprint = {2111.15347},
  archivePrefix = {arXiv},
  url = {https://arxiv.org/abs/2111.15347},
}
Figure